000341839 001__ 341839
000341839 005__ 20230827173328.0
000341839 0247_ $$2CORDIS$$aG:(EU-Grant)101105954$$d101105954
000341839 0247_ $$2CORDIS$$aG:(EU-Call)HORIZON-MSCA-2022-PF-01$$dHORIZON-MSCA-2022-PF-01
000341839 0247_ $$2originalID$$acorda_____he::101105954
000341839 035__ $$aG:(EU-Grant)101105954
000341839 150__ $$aLocalize and Controlled co-delivery of AuNPs conjugated siRNA by Cationic Shear-thinning Gel Matrix for Treatment of Arthritis (DesiRTA)$$y2024-01-01 - 2025-12-31
000341839 372__ $$aHORIZON-MSCA-2022-PF-01$$s2024-01-01$$t2025-12-31
000341839 450__ $$aDesiRTA$$wd$$y2024-01-01 - 2025-12-31
000341839 5101_ $$0I:(DE-588b)5098525-5$$2CORDIS$$aEuropean Union
000341839 680__ $$aArthritis is a common metabolic and immune associate disease that causes chronic pain and inflammation in a joint. Approximately
312 million people are affected by arthritis globally. It affects adults of all ages, both sexes, and all races and ethnicities, but the
prevalence in women is more than in men. Professional organizations have established many arthritis treatment regimens and
management guidelines; in those nonsteroidal anti-inflammatory drugs (NSAIDs), steroids and biologicals are the main ones. These are
effective against the disease aggressiveness and pain up to some extent, but the problem is this treatment is only symptomatic and
requires taking them lifelong; in that case, these drugs cause severe health problems and again increase the economic burden. For
these reasons, we need to develop a therapeutic technique and medication that can eliminate the symptom and causes of the disease
forever and prevent the ever-increasing number of patients worldwide. DesiTRA projects are an effort in the same vein to develop an
effective therapeutic alternative for arthritis that will avoid the aggravation of disease symptoms and cause of the disease together,
without causing any health-associated side effects. In this, mainly gold nanoparticle (AuNPs) conjugated siRNA will be delivered at the
disease site locally. Modified polysaccharides will increase the stability and release rate of AuNPs-siRNA, and these assemblies will be
delivered very controlled and precisely through a synovial fluid mimicking the shear-thinning hydrogel system. The ambitious
project will be conducted at two different groups and laboratories in Ireland and Portugal. The project involves experienced
researchers of other but related areas that will allow applicants to work in multidisciplinary aspects. The prestigious fellowship will
provide a plate form of renowned subject experts, and exposure to international collaborators will provide a unique opportunity to
grow as a true researcher
000341839 909CO $$ooai:juser.fz-juelich.de:1011198$$pauthority:GRANT$$pauthority
000341839 909CO $$ooai:juser.fz-juelich.de:1011198
000341839 980__ $$aG
000341839 980__ $$aCORDIS
000341839 980__ $$aAUTHORITY